Dual HDAC and PI3K Inhibitor: A Novel Potential Therapeutic Option in Cushing Disease.
- 2021
Available online through MWHC library: 1999- June 2013, Available in print through MWHC library: 1999 - 2006
English
0021-972X
10.1210/clinem/dgaa845 [doi] 5986702 [pii]
*Phosphatidylinositol 3-Kinases
*Pituitary ACTH Hypersecretion
Histone Deacetylase Inhibitors/tu [Therapeutic Use]
Humans
Phosphoinositide-3 Kinase Inhibitors
Pituitary ACTH Hypersecretion/dt [Drug Therapy]
MedStar Washington Hospital Center
Medicine/Endocrinology
Journal Article